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We report in vitro studies of the interactions between purified E. coli RNA polymerase and DNA from 
the regulatory region of the E. coli galactose operon which carries a point mutation that simultaneously 
stops transcription nitiation at the two normal start points, $1 and $2. In the presence of this point muta- 
tion, transcription i itiates at a third start point 14/15 bp downstream of $1, showing that inactivation of 
the two normally active promoters, P1 and P2, unmasks a third weaker promoter, P3. Transcription i itia- 
tion in the gal operon is normally regulated by the cyclic AMP receptor protein, CRP, that binds to the 
gal regulatory region and switches transcription from P2 to PI. With the point mutation, CRP binding swit- 
ches transcription from P3 to P1, although the formation of transcriptionally competent complexes at P1 
is very slow. The results are discussed with respect to the mechanism oftranscription activation by the CRP 
factor and the similarities between the regulatory regions of the galactose and lactose operons. 
Galactose operon; Tandem promoter; Promoter mutation; RNA polymerase; cyclic AMP receptor protein; 
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1. INTRODUCTION 
The regulatory region of the Escherichia coli 
galactose operon is unusual as it contains two 
overlapping but distinct promoters, P1 and P2, 
that are regulated by the cyclic AMP receptor pro- 
tein, CRP [1]. The transcription start point for the 
P2 promoter is at $2, 5 bp upstream of $1, the 
transcription start point of the P1 promoter 
(fig.l). In vivo, gal operon transcription usually 
starts at $2. However in conditions where the in- 
tracellular level of cAMP rises, the cAMP-CRP 
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complex binds to the gal promoter region and 
switches transcription from P2 to P1 [2]. 
In recent work, we and others have measured the 
effects of over 60 different point mutations in the 
gal operon promoter region [3-8]. Surprisingly, 
with one exception, none of the mutations cause 
drastic reductions in expression from the gal pro- 
moter region. This can be readily explained as the 
DNA sequences necessary for P1 and P2 function 
are distinct and, thus, mutations that knock out P1 
leave P2 active and vice versa. The exception is a 
point mutation at - 12 that falls at the intersection 
of the P1 and P2 -10  hexamer sequences (see 
fig. 1): in vivo, this mutation causes a > 95°70 reduc- 
tion in expression from the gal operon regulatory 
region [6]. Here we report the properties, in vitro, 
Published by Elsevier Science Publishers B.V. ( iomedical Division) 
00145793/87/$3.50 © 1987 Federation of European Biochemical Societies 189 
Volume 219, number l FEBS LETTERS July 1987 
of the gal operon regulatory region DNA carrying 
this unique mutation that simultaneously knocks 
out both promoters. We show that the absence of 
P1 and P2 unmasks a third overlapping promoter 
to which RNA polymerase can bind and initiate 
transcription 14-15 bp downstream of S1. Fur- 
ther, we have investigated the interactions between 
CRP and RNA polymerase at the gal regulatory 
region carrying this mutation at -12 .  
2. MATERIALS AND METHODS 
The gal operon regulatory region was cloned on 
a 144 bp DNA fragment between the EcoRI and 
HindIII sites of pBR322 as described [9]. The gal 
fragment carried either the wild type promoter se- 
quence [4], point mutations at - 12 or - 19 [6] or 
the A420 deletion [10]. Transcription and footprint 
experiments were performed on PstI-HindIII or 
PstI-BstEII fragments isolated from these con- 
structions as before [9,11]. 
'Run-off '  transcription assays were performed 
exactly as previously described by us [9]. Footprint 
experiments were as described by Spassky et al. 
[11]. 1-2 nM end-labelled DNA fragments were 
incubated in the presence or absence of 100 nM 
CRP and 2001tM cAMP in 40 mM Tris, pH 8, 
10 mM MgC12, 100 mM KC1, 0.1 mM 
dithiothreitol, 5°7o glycerol. After 15 min, 150 nM 
RNA polymerase was added and after a further 
15 rain the footprint was determined by adding 
75 ng/ml DNase I or the copper-ortho- 
phenanthroline mix described by Sigman et al. 
[12]. Digestion was stopped after 20 s by phenol 
extraction and alcohol precipitation. Samples were 
analysed on 10°70 sequencing els followed by 
autoradiography to visualise the footprint. 
3. RESULTS 
3.1. Inactivation o f  gal P1 and gal P2 reveals a 
new transcription start point 
The sequence of the gal operon promoter egion 
is shown in fig.1 together with the transcription 
start points and corresponding -10  hexamer se- 
quences for the P1 and P2 promoters. The position 
of the mutation at - 12 that disrupts both the P1 
and P2 - I0  hexamer sequences i also indicated. 
The 890 bp PstI-HindIII fragment, illustrated in 
fig. 1, was isolated carrying either the wild type gal 
pBR 322 P-GAL Hin d III 
T 
TT TC ITAC CATA A[iCC TA AT GG AG "~ 
Psf I 
T 
P2 T AT GC T I . . . . . .  AUU- 53n  
P1 ITATGGT . . . . . .  AUA-  48n,.~ 
P3 tTACCAT~ . . . . . .  AA_ U- 35n 
Fig. 1. Diagram of the PstI-HindIII fragments used in this study. The bar epresents the DNA sequence consisting of 
750 bp from the Pstl site to the EcoRI site of pBR322 (open) and a 144 bp EcoRI-HindIII fragment carrying the gal 
operon promoter region (shaded). The position of the BstEII site just upstream of the HindIII site is marked. Below 
the bar is shown in detail an expanded segment of the gal promoter region with the nucleotide sequence of the upper 
strand of the DNA around the transcription start points. For gal P1, P2, and the P3 promoter described here, the - l0 
hexamer sequences are indicated by brackets and the tr~/nscr~ption start points are shown by the end of a wavy arrow. 
Above each arrow is marked the RNA sequence at the 5 '-end of the transcript and the distance in bases from that start 
point to the HindIII end of the fragment. The gal sequence isnumbered ~vith respect to the P1 transcription start point: 
the position of the transition at - 12 that inactivates both P1 and P2 is indicated. 
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promoter  sequence or the mutat ion at - 12. Af ter  
addi t ion of  puri f ied RNA polymerase,  run-of f  
transcripts were made and analysed on 
po lyacry lamide gels (fig.2). With the wild type gal 
promoter  sequence, the major  transcr ipt  starts at 
$2 and runs 53 bases to the end of  the fragment:  
a minor  band 48 bases long is due to some initia- 
t ion at S1 (fig.2a). With  the fragment carrying the 
mutat ion at - 12, no transcripts initiate at S1 or $2 
but a new band appears that is 35 bases long 
cz b c d e 
53n 
35n 
25n 
P2 
"~,----- P 1 
P3 
P2 53 n 
P1 ~ ~ 48n 
43n 
38n 
P3 -- 35n 
-- 25n  
Fig.2. In vitro transcription experiments. The figure shows autoradiograms of gels run to analyse RNA made in run 
off transcription assays. The gels were calibrated and the length in bases of each band is indicated together with the 
promoter that is responsible for each band. The DNA fragments used were (a) PstI-HindIII fragment carrying the wild 
type ga! promoter sequence, (b) PstI-HindIII fragment carrying the mutation at - 12, (c) PstI-BstEII fragment carrying 
the mutation at - 12, (d) PstI-HindIII fragment carrying the wild type gal promoter sequence but a deletion from - 29 
to -92 ,  (e) PstI-BstEII fragment carrying the deletion from -29  to -92 .  
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(fig.2b). To identify the origin of  this transcript the 
PstI-HindIII f ragment carrying the mutat ion at 
- 12 was shortened by restrict ion with BstEII; this 
cuts l0 bp before the HindIII site (f ig. l ) .  A f ter  
restriction, the 35 base transcript is reduced to 25 
bases (fig.2c), showing that this transcript is due to 
RNA polymerase initiating transcr ipt ion at + 14 or 
+ 15 and moving r ightwards to the end of  the frag- 
-12 -12 -19 
mutation ~ I I I 1 I 
lane a b c d e f g h i j k t m n o 
CRP + ++ + + + -+ 
time (rains) 1/2 2 5 15 30 60 kz 2 S 15 30 60 2 2 
P1 
P3- - - -~  
= ~.8n 
35n 
Fig.3. Kinetics of transcription i itiation. RNA polymerase was incubated with the PstI-HindlII fragment carrying the 
mutation at - 12 in the absence (lanes a- f )  or presence (lanes h-m) of cAMP-CRP. After the different imes shown, 
nucleoside triphosphates and heparin were added and the transcripts were analysed by gel electrophoresis a shown in 
the figure. Lanes n and o show an experiment with DNA carrying a mutation at - 19 that gives transcription from P1 
under all conditions. 
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ment. Fig.1 shows the position and orientation of 
the transcription start point and indicates a plausi- 
ble -10  sequence, 5 ' -TACCAT-3 ' ,  from +2 to 
+7. 
We reasoned that the transcript starting at 
+ 14/+ 15 must be due to a third promoter (la- 
belled P3 in fig. 1) that is masked in the presence of 
P1 or P2 but which becomes active when P1 and 
P2 are simultaneously inactivated. To test this 
hypothesis we repeated the run-off transcription 
experiments on a PstI-HindlII  fragment carrying 
the wild type gal promoter sequence with a deletion 
of the sequence from - 29 to - 92 that eliminates 
the -35  regions of both P1 and P2. Fig.2d,e 
shows that, with the deletion, transcripts of 53, 48 
and 35 bases are made which are reduced to 43, 38 
and 25 bases when the fragment is shortened with 
BstEII. The 53 and 48 base transcripts originate 
from P2 and P1 respectively, confirming our 
previous observation that both gal promoters are 
partially active in the absence of the normal - 35 
region sequences [10]. The 35 base transcript must 
start at + 14/+ 15 confirming that the P3 pro- 
moter becomes active when both P1 and P2 are 
disrupted. 
To assess the strength of the P3 promoter we 
determined the time for formation of 
transcriptionally-competent complexes after RNA 
polymerase was added to gal DNA carrying the 
mutation at -12 .  To do this, polymerase was 
mixed with DNA and, at different ime points, a 
mix of the four nucleoside triphosphates was 
added together with heparin. F ig.3a-f  shows that, 
under our conditions, incubation times of at least 
15 rain are required for the formation of com- 
plexes that initiate transcription at + 14/+ 15. 
3.2. Interactions between CRP and RNA 
polymerase at the gal regulatory region 
carrying the mutation at -12  
Although the mutation at - 12 destroys both the 
P1 and P2 - 10 hexamer sequences, it does not af- 
fect the site for CRP binding which is located be- 
tween -30  and -50  [13]. We and others have 
shown that, with the wild type gal promoter 
region, cAMP-CRP switches transcription from 
P2 to P1 [1,11]. Fig.3h-m shows that when 
cAMP-CRP is added to PstI-HindlII fragments 
carrying the mutation at - 12, transcription from 
the start point at + 14/+ 15 is blocked and RNA 
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Fig.4. DNase I footprint analysis. Combinations of 
RNA polymerase and cAMP-CRP as shown were 
incubated with end-labelled PstI-HindIII fragment 
carrying the mutation at -12. After incubation with 
DNase I the pattern of bands produced was analysed on 
a calibrated sequencing-type polyacrylamide gel and 
revealed by autoradiography as shown. The numbers 
refer to positions in the gal promoter sequence. 
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Fig.5. Footprint analysis using orthophenanthroline-copper ions as an artificial nuclease. End-labelled PstI-HindlII 
fragments carrying a mutation at - 19 (lanes a-c)  or at - 12 (lanes d - f )  were incubated with combinations of RNA 
polymerase and cAMP-CRP as shown and subjected to footprint analysis. The pattern of fragments generated were 
analysed on calibrated polyacrylamide gels that were revealed by autoradiography. 
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polymerase switches to the S1 start at + 1. 
However, formation of complexes that initiate 
transcription at S1 is slow, with a half-time of 
20-25 min under these conditions. In parallel ex- 
periments with the wild type gal P1 promoter, 
transcriptionally-competent complexes form in less 
than 2 min in the presence of cAMP-CRP ([11] 
and fig.3n-o). 
Fig.4 shows an analysis, using DNase I foot- 
printing [14], of the binding of CRP and RNA 
polymerase to gal promoter DNA carrying the 
mutation at -12 .  Lane a shows the pattern of 
bands formed when end-labelled Pstl-HindlII 
DNA fragments covering the gal promoter egion 
were treated with DNase I. Lane b shows that 
cAMP-CRP alone binds normally giving a foot- 
print between -30  and -50  identical to that 
reported [11,15,16]. Lane c shows that RNA 
polymerase alone gives a very weak footprint, 
unlike that found when RNA polymerase binds to 
P2 [11,16,17], confirming that the complex be- 
tween RNA polymerase and P3 is unstable. Lane 
d shows the protection due to both RNA 
polymerase and cAMP-CRP: clearly a tight com- 
plex is formed that gives extensive protection from 
+ 17 to -65 .  Comparison of this footprint with 
published data for the CRP-induced binding of 
RNA polymerase to gal P1 [11,16,17] shows that, 
in this case, RNA polymerase is indeed bound at 
P1. To confirm this, we compared the complexes 
formed between cAMP-CRP, RNA polymerase 
and gal DNA carrying either the mutation at - 12 
or a mutation at - 19 that inactivates P2 such that 
P1 is the sole functional promoter [6,8]. In this ex- 
periment we used the nuclease activity of 
1,10-phenanthroline-copper ions [12] as an alter- 
native to the more bulky DNase I. The results in 
fig.5 show that, in the presence of cAMP-CRP, 
RNA polymerase creates an extensive footprint 
that is identical whether the gal promoter carries 
the mutation at - 12 or at - 19 (lanes c and f). In 
contrast, with polymerase alone, a strong footprint 
is seen with the mutation at -19  (lane b, due to 
polymerase at P1), whereas a weak footprint is 
found with the mutation at -12  (lane e, due to 
polymerase at P3). 
4. DISCUSSION 
Amongst the many point mutations that have 
been isolated throughout he E. coli gal operon 
promoter egion, the mutation at - 12 is unique as 
it simultaneously inactivates both P1 and P2 and 
almost totally eliminates expression in vivo from 
the gal regulatory region. However in the absence 
of PI and P2 a third promoter, which we have 
labelled P3, is unmasked. This promoter initiates 
transcription slowly at + 14/+ 15 and, like many 
weak promoters, forms complexes with RNA 
polymerase that give weak footprints. Most 
probably the low expression from this promoter in 
vivo is a reflection of its weakness. Interestingly 
the DNA sequence upstream of this start point car- 
ries plausible correctly spaced - 10 and - 35 hex- 
amer sequences, 5 ' -TACCAT-3 '  and 5 ' -TT-  
GTTA-3 ' ,  that, according to the established con- 
sensus, should create a stronger promoter [18]. 
We and others have noted the striking 
similarities between the arrangement of signals in 
the lac and gal regulatory regions [11,19,20]: in 
both cases there are two overlapping promoters, 
P1 and P2, one of which is stimulated and the 
other of which is blocked by cAMP-CRP. This 
work suggests a third common feature, as the gal 
P3 promoter that initiates transcription at 
+ 14/+ 15, is strikingly similar to the Pl15 pro- 
moter in the lac operon that initiates transcription 
at +13 [21]. To explain the existence of this 
'downstream' promoter, which was found after an 
analysis of transcripts made by the lac operon 
regulatory region carrying a mutation at + 1, 
Peterson and Reznikoff [21] suggest hree possible 
explanations: either it is an accident, an evolu- 
tionary remnant or an 'antenna' allowing loosely 
bound polymerase to associate near P1, the major 
functional promoter. In our view the existence of 
a similar promoter in the case of the gal operon 
allows us to eliminate the accident hypothesis but, 
to date, we have no evidence to favour one of the 
alternatives. 
In their study, Peterson and Reznikoff [21] 
noted that cAMP-CRP diverted RNA polymerase 
from the alternative PI15 promoter to lac P1. 
Similarly, in the gal case, cAMP-CRP blocks the 
P3 promoter and stimulates, albeit slowly, open 
complex formation at gal P1. Presumably the lack 
of expression from the gal regulatory region carry- 
ing the mutation at - 12 in vivo in crp + cya + cells 
is due to the fact that cAMP-CRP acts too slowly. 
However, from our studies in vitro we can draw 
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two clear conclusions concerning the action of 
CRP. Firstly, it is generally thought that CRP 
stimulates transcription by acting at an early stage 
during the recognition of promoter DNA by RNA 
polymerase probably by directly contacting incom- 
ing polymerase [20,22-241. The - 10 hexamer se- 
quence cannot be essential for this step as CRP 
acts even when the hexamer is altered from 
5 ' -TATGGT-3 '  to 5 ' -CATGGT-3 ' .  Secondly, the 
footprint data (figs 4 and 5) clearly show that CRP 
tightens polymerase binding to gal promoter DNA 
carrying the mutation at - 12. We have previously 
studied CRP binding to the gal promoter egion 
carrying mutations or deletions that weakened 
CRP binding: we showed that in the presence of 
RNA polymerase, CRP binding was tightened 
[11]. Here we have studied polymerase binding to 
the gal promoter egion carrying a mutation that 
weakens RNA polymerase binding: we have shown 
that in the presence of CRP, polymerase binding is 
tightened. Hence there is a clear cooperativity be- 
tween CRP and RNA polymerase binding to gal 
promoter DNA. We suggest hat this is due to a 
direct contact between the two proteins that most 
probably is essential for CRP to stimulate 
transcription initiation. 
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